Acupuncture for Irritable Bowel Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00065403|
Recruitment Status : Completed
First Posted : July 23, 2003
Last Update Posted : August 18, 2006
Little is known about acupuncture's efficacy for Irritable Bowel Syndrome (IBS). This trial uses a manualized acupuncture treatment format that closely follows clinical practice and allows flexibility in designing individualized treatments. In addition, a second parallel qualitative study will follow a subgroup of patients throughout the trial to explore the relationships between patients' interpretations and understandings (what anthropologists call "meaning") of irritable bowel and their response to treatment. Cortisol levels (an important stress hormone) will also be assessed.
This will be a 3-arm trial: Active acupuncture, placebo acupuncture, and wait list.
|Condition or disease||Intervention/treatment||Phase|
|Irritable Bowel Syndrome||Device: Acupuncture||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||260 participants|
|Intervention Model:||Parallel Assignment|
|Study Start Date :||February 2004|
|Study Completion Date :||September 2005|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00065403
|United States, Massachusetts|
|Harvard Medical School|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Ted Kaptchuk, OMD||Harvard Medical School (HMS and HSDM)|